Steven R. O'NEIL

Person

Wayland, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, an...
- Patent number 12,275,791
- Issue date Apr 15, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...
- Patent number 12,215,157
- Issue date Feb 4, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 11,524,992
- Issue date Dec 13, 2022
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glypican-3-binding fibronectin based scaffold molecules
- Patent number 10,584,160
- Issue date Mar 10, 2020
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...
- Publication number 20250206827
- Publication date Jun 26, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20250154261
- Publication date May 15, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND FLT3
- Publication number 20240117054
- Publication date Apr 11, 2024
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20230312686
- Publication date Oct 5, 2023
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...
- Publication number 20230272041
- Publication date Aug 31, 2023
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20220380459
- Publication date Dec 1, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...
- Publication number 20220195065
- Publication date Jun 23, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20220153848
- Publication date May 19, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20220089760
- Publication date Mar 24, 2022
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF
- Publication number 20220025037
- Publication date Jan 27, 2022
- Dragonfly Therapeutics, Inc.
- Hemanta Baruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS,...
- Publication number 20210221894
- Publication date Jul 22, 2021
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON
- Publication number 20210214436
- Publication date Jul 15, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20200262893
- Publication date Aug 20, 2020
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- G01 - MEASURING TESTING
Information Patent Application
GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES
- Publication number 20190077844
- Publication date Mar 14, 2019
- Bristol-Myers Squibb Company
- Dasa LIPOVSEK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Steven R. O'NEIL

Person

Patents Grantslast 30 patents

Multi-specific binding proteins that bind HER2, NKG2D, and CD16, an...

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, an...

Glypican-3-binding fibronectin based scaffold molecules

Glypican-3-binding fibronectin based scaffold molecules

Patents Applicationslast 30 patents

MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

PROTEINS BINDING NKG2D, CD16 AND FLT3

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

Formulation, Dosage Regimen, and Manufacturing Process for Heterodi...

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR MULTI-SPECIFIC...

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

ANTIBODY VARIABLE DOMAINS TARGETING DLL3, AND USE THEREOF

PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS,...

MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES

GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES